tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (FR:SAN)
:SAN
France Market
SAN
Sanofi
RESEARCH TOOLSreports
Advertisement

Sanofi (SAN) Stock News & Sentiment

Compare
263 Followers
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
Premium
Company Announcements
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
20d ago
SNYNF
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
Premium
Company Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
22d ago
REGN
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
Premium
Company Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
22d ago
REGN
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
Premium
Company Announcements
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
22d ago
SNYNF
Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects
Premium
Ratings
Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects
25d ago
SNY
SNYNF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SNYNF Earnings this Week: How Will it Perform?
27d ago
Sanofi’s Rilzabrutinib Trial: A Potential Game-Changer for IgG4-related Disease
Premium
Company Announcements
Sanofi’s Rilzabrutinib Trial: A Potential Game-Changer for IgG4-related Disease
1M ago
SNYNF
More FR:SAN News >

SAN News on the Web

Sanofi (ENXTPA:SAN): Evaluating Valuation After Positive Dupixent Trial Results and FDA Priority Review
Simply Wall St
Neutral
Are Sanofi Shares Offering Hidden Value After Pipeline Expansion News in 2025?
Simply Wall St
Bullish
Sanofi And Regeneron's Dupixent Meets Primary Goal In Phase 3 Allergic Fungal Rhinosinusitis Study
rttnews
Neutral
Sanofi (ENXTPA:SAN) Valuation: Is the Pharma Giant Trading Below Its True Worth?
Simply Wall St
Neutral
Novavax Completes Marketing Authorization Transfers For Nuvaxovid To Sanofi
rttnews
Neutral
We Think Sanofi's (EPA:SAN) Healthy Earnings Might Be Conservative
Simply Wall St
Bullish
Is Now the Moment to Revisit Sanofi Shares After a Recent 11% Jump?
Simply Wall St
Neutral
Medidata And Sanofi Expand Collaboration To Advance Clinical Research Innovation
rttnews
Neutral

News Score - Last 7 Days

Neutral
FR:SAN
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?
1 articles about FR:SAN were published this week. In an average week, 3.5 articles are published.
    What is FR:SAN’s weekly average amount of articles?
    In an average week, 3.5 articles about FR:SAN are published.
      What is FR:SAN’s News Sentiment?
      50% of articles about FR:SAN were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        ELMDElectromed
        0RJTRedcare Pharmacy
        KRMDREPRO-MED Systems
        0O9BAlmirall
        ADMAADMA Biologics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing